Skip to content

Effect of Rohitakabhaya kwatha in management of Non alcoholic fatty liver disease.

CLINICAL EVALUATION OF ROHITAKABHAYA KWATHA IN NON-ALCOHOLIC FATTY LIVER DISEASE - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/095571
Enrollment
30
Registered
2025-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Sponsors

Nancy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient having ultrasonographical evidence of NAFLD and BMI (25-40 Kg/m2). 2. Patient s having altered serum liver enzymes levels defined as serum ALT and AST more than normal ( >40 IU/L) but less than two times of the upper limit of the normal value( 3. Subjects of either sex, age group 20-60 years who are non-alcoholics or they have history of alcohol intake less than 20 g/day.

Exclusion criteria

Exclusion criteria: 1. Patients who is unwilling to participate in study. 2. Patients having serum liver enzymes AST and ALT more than 2 times of upper normal limit.(i.e.AST more than 76 U/L; ALT more than 82 U/L) 3. Patients having ultrasonographical evidence of cirrhosis or necrosis of liver. 4. Patient who is consuming alcohol. 5. Patient testing positive for hepatitis B & hepatitis C, uncontrolled diabetes, malignancy of liver or having any other comorbidity.

Design outcomes

Primary

MeasureTime frame
Relief in subjective parameters: 1.Utklesha 2. Chardi 3. Aruchi 4. Hridkantadaha 5. UdarashoolaTimepoint: First assessment 15 days post- treatment initiation. Second Assessment- 15 days after the first assessment. Third Assessment- 15 days after the second assessment.

Secondary

MeasureTime frame
Relief in objective parameters: 1. Anthropometric measurements - Body weight, BMI 2. Biochemical tests - FBS, ALT, AST, GGT, AST/ALT Ratio, Alkaline phosphatase 3. Lipid profile - Serum cholesterol, Triglycerides, LDL, HDL, VLDL 4. Radiological - USG Whole Abdomen Timepoint: Assessment will be done on day 0 and 45 day

Countries

India

Contacts

Public ContactNancy

Quadra Institute of Ayurveda and Hospital Roorkee Haridwar

charu22jan@gmail.com7060398172

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026